[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.30. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
March 3, 1999

Celecoxib for Arthritis

Author Affiliations
 

Not Available

Not Available

JAMA. 1999;281(9):786. doi:10.1001/jama.281.9.786-JFD90001-2-1

The FDA has approved celecoxib (Celebrex, GD Searle, Skokie, Ill) for relief of the signs and symptoms of osteoarthritis and for relief of the signs and symptoms of rheumatoid arthritis in adults. Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) whose mechanism of action is believed to be due to inhibition of prostaglandin synthesis, primarily via inhibition of cyclooxygenase-2 (COX-2). At therapeutic doses in humans, it does not appear to inhibit COX-1 (believed by many to be important in the gastrointestinal system).

First Page Preview View Large
First page PDF preview
First page PDF preview
×